Department of Drug Regulatory Affairs, Graduate School of Pharmacy-GTU, Gandhinagar, Gujarat, India
 Review Article   
								
																Current Regulatory Aspects of Phytopharmaceutical in India and Europe 
																Author(s): Panchal Mittal Maheshbhai and Pathan Asmatbanu*             
								
																
						 The pharmaceutical and cosmetic industries are becoming increasingly interested in plant-based natural products like as extracts, bioactive fractions, essential oils, 
  phytomolecules, flavours, and perfumes. PhytoPharmaceuticals are a novel class of medication that includes enriches fractions containing at least one phytonutrient, with 
  one biomarker; at least four unique chemical indicators are required. This category paves the path for the future for the plant-based concentrated fraction to be utilised 
  as a medicine, which is not documented in Ayurveda texts. It was crucial to understand the chemical makeup and quantity of pharmacologically active substances. The 
  formulation's active components the provisions for synthetic medications are insufficient or ineffective. Botanical-based goods are relevant. In India AYUSH and CDSCO have 
  taken this into mind, As the need.. Read More»
						  
																DOI:
								10.37421/2167-7689.2022.11.303															  
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report